
|Articles|October 25, 2012
Risk of VTE Increased in New Users of Drospirenone
A retrospective cohort study of more than a half million new users of hormonal contraception shows that drospirenone is associated with a higher risk of thrombotic events than contraceptives containing low-dose estrogen.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA initiates removal of boxed warnings, requests updated labeling for menopausal hormone therapy
2
Women’s waist size could help identify early cognitive vulnerability after menopause
3
Prenatal alcohol use linked to increased offspring addiction risk
4
Persistent gaps in contraception access identified
5
















